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Abstract
Background: Better management of affective and somatoform disorders may reduce consultation
rates in primary care. Somatoform disorders are highly prevalent in primary care and co-morbidity
with affective disorders is substantial, but it is as yet unclear which portion of the health care use
may be ascribed to each disorder. Our objective was to investigate the use of primary care for
undifferentiated somatoform disorders, other somatoform disorders, anxiety and depressive
disorders prospectively.
Methods: In eight family practices 1046 consulting patients (25–79 yrs) were screened and a
stratified sample of 473 was interviewed. Somatoform disorders, anxiety and depressive disorders
were diagnosed (DSM IV) using SCAN 2.1. The electronic records of 400 participants regarding
somatic diseases, medication and healthcare use were available through their family physicians (FP).
Results: In the follow-up year patients with psychiatric disorders had more face-to-face contacts
with the FP than patients who had no psychiatric disorder: average 7–10 versus 5. The impact on
the use of primary care by patients with somatoform disorders was comparable to patients with
depressive or anxiety disorders. Undifferentiated somatoform disorders had an independent
impact on the use of primary care after adjustment for anxiety and depressive disorders, resulting
in 30% more consultations (IRR 1.3 (95% CI: 1.1–1.7)). Anxiety disorders had no independent
effect.
Conclusion: Health care planning should focus on the recognition and treatment of somatoform
as well as affective disorders.
Background
Psychiatric disorders may have a significant impact on
consultation rates in primary care. Patients with anxiety
and depressive disorders report more use of health care
than patients without these disorders [1,2]. A similar
assumption can be made for somatoform disorders, con-
sidering the predominant presentation of physical symp-
toms [3-5]. Additionally, hypochondriacal beliefs and a
high somatic concern have found to be related to a high
utilization of health care [6,7].
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With an estimated prevalence rate between 13% and 27%,
undifferentiated somatoform disorder is the most preva-
lent somatoform disorder in primary care [8,3]. Somatiza-
tion disorder and hypochondriasis are encountered less,
with prevalence rates below 5% [9]. In DSM-IV the diag-
nosis of undifferentiated somatoform disorder (USD) can
be made when at least one medically unexplained physi-
cal symptom leads to substantial impairment for a mini-
mum of 6 months [10]. Hence, health-seeking behaviour
is not an explicit part of the definition.
The comorbidity of somatoform disorders with affective
disorders is substantial [11,12]. In an earlier report on the
SOUL-study, we found that in primary care one out of two
patients with an anxiety/depressive disorder had a comor-
bid somatoform disorder [8]. It is as yet unclear which
portion of the health care use may be ascribed to each dis-
order. High health care use in patients with an anxiety or
depressive disorder might well be the result of a comorbid
somatoform disorder or vice versa.
We prospectively studied the use of primary health care by
patients with DSM-IV diagnoses of undifferentiated
somatoform disorders, other somatoform disorders, anxi-
ety and depressive disorders. We aimed at assessing the
independent contribution of each of the disorders to pri-
mary health care utilization while controlling for somatic
disease.
Methods
Study design
The SOmatization study of the University of Leiden
(SOUL-study) was designed as a cohort study with a two-
phase selection procedure [13] for clinical assessment at
baseline. In the initial stage high-risk patients were identi-
fied by means of screening questionnaires. In the second
phase all high-risk patients and a sample of 15% of the
low risk patients were invited for a psychiatric diagnostic
interview.
All interviewed patients were followed prospectively. After
a follow-up of 6 months a second set of questionnaires
was sent to provide for information on self-reported
health care use and persistence of symptoms. After a fol-
low-up of 12 months data were gathered on health care
use in primary care using the electronic medical records of
the FP.
The ethics committee of the Leiden University Medical
Center approved of the study. Informed consent was
obtained from the participants.
Setting
The study took place in eight university-affiliated general
practices in the vicinity of Leiden, The Netherlands, with
approximately 21.500 enlisted patients.
In the Netherlands the FP is the central gatekeeper for the
provision of health care. All patients are listed with one FP
and primarily consult him or her for all health problems
[14]. The FP indicates whether a referral to secondary care
is appropriate. FPs play an important part in mental
health care [15]. If a referral is indicated for a somatoform
or an affective disorder, the Dutch FP has the option of a
primary care mental health psychologist or a mental
health service.
The electronic medical records of the FP cover all informa-
tion, including reports from laboratories and specialists.
As a consequence, FP records facilitate research on clinical
assessment of reported symptoms.
Patient sample
Between April 2000 and December 2001 a sample of 1778
attendees, aged 25 to 80, were sent the screening question-
naires by mail. After two weeks non-responders were sent
a reminder including a copy of the questionnaires. For
each practice the researchers included consecutive
patients on 13 to 30 arbitrary days within a three-month
period. To avoid language problems the study was limited
to Dutch natives. Patients were excluded if they were una-
ble to participate in an interview due to handicaps such as
deafness, aphasia, or cognitive impairment. A total
number of 1046 patients (59%) returned the question-
naire and indicated that they were willing to participate.
Participants completed the Physical Symptom Checklist
(PSC) [16] and the Hospital Anxiety and Depression Scale
[17] (HADS). A total score of 15 or more on the HADS or
a score of 5 or more on the PSC defined the high-risk sam-
ple [18].
A sample of patients was contacted by mail and telephone
for an interview in person at their home address and 473
out of 589 responded (80%). We obtained complete fol-
low-up data on health care use of 400 patients (85%) (See
Figure 1).
Clinical assessment of psychiatric disorders
WHO-certified psychologists used the Schedules for Clin-
ical Assessment in Neuropsychiatry (SCAN 2.1 [19]) for
the subsequent psychiatric diagnostic interviews.
Throughout the study we held regular sessions with the
interviewers to maintain the diagnostic standards. During
the interview patients were asked about concurrent physi-
cal illnesses, and the interviewers made the clinical deci-
sion whether symptoms were 'unexplained' or not. TheBMC Family Practice 2008, 9:5 http://www.biomedcentral.com/1471-2296/9/5
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FP-researcher (IAA) supervised all interviews for medical
diagnostic data. Whenever necessary medical diagnostic
data concerning symptoms were obtained from the indi-
vidual general practitioners. When doubt remained the
symptom was regarded as 'explained'.
Current disorders were diagnosed with special emphasis
on impairment. Scoring algorithms on DSM-IV diagnoses
were derived from the official computer program. All
chronic somatoform disorders lasting at least 6 months
were diagnosed: 'Acute pain disorder' and 'Somatoform
disorder Not Otherwise Specified' were excluded. In this
paper chronic pain disorders were regarded as undifferen-
tiated somatoform disorders, and as such placed in the
same group [20].
Medical consumption
Self-report data on use of healthcare were obtained after a
follow-up of 6 months. In the questionnaire patients were
asked to report contacts with a psychiatrist, psychologist
or social worker, visits to hospital or specialist and admis-
sion to hospital.
The electronic medical records of the FP were available
through the central database of the family practice regis-
tration network Leiden RNUH-LEO, and provided data on
medical history ('health problems'), practice contacts and
prescriptions.
The FP-consultation rate was computed by counting all
face-to-face contacts within office hours in the year after
baseline assessment. The FP-prescription rate was com-
puted by counting all prescriptions issued by the FP in the
year after selection. The prescriptions for psycholeptics
Flow-chart of the design and response of the SOUL study Figure 1
Flow-chart of the design and response of the SOUL study.
Screening questionnaire consulting population in general practice 
Response 1046 out of 1778 (59%) 
↓       ↓ 
screening positive 506  screening negative 540 
Total high risk sample  Random low risk sample (83 out of 540) 
↓       ↓ 
Diagnostic Interview 
Response 404 out of 506 (80%)  Response 69 out of 83 (83%)  total 473 
↓       ↓ 
Follow-up questionnaire 6 months  
Response 348 out of  404 (86%)  Response 62 out of 69 (90%) 
DSM-IV diagnoses: response 123 out of 140  DSM-IV diagnoses: response 4  out of 4 
    
↓       ↓ 
Follow-up electronic medical records 12 months 
Response 339 out of  348 (97%)  Response 61 out of 62 (98%)  total 400 
DSM-IV diagnoses: response 122 out of 123  DSM-IV diagnoses: response  4 out of 4 
 
 Response  85% BMC Family Practice 2008, 9:5 http://www.biomedcentral.com/1471-2296/9/5
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(antipsychotics, anxiolytics, hypnotics & sedatives, antide-
pressants) were calculated separately.
Health status
Somatic morbidity was assessed at baseline by means of
the Cumulative Illness Rating Scale (CIRS-14), a morbid-
ity index that includes a wide range of diseases. It classifies
severity of disease in terms of impairment and required
treatment (ranging from 0 to 4) for 14 categories (organ
systems). When two diseases are present within a cate-
gory, the disease with the higher score is counted. A total
morbidity score is computed by adding the severity
weights [21-23]. We computerized the calculation of this
score, using all available baseline data from RNUH-LEO.
We excluded the category 'psychiatric' for the somatic
morbidity score. The category 'psychiatric' will be pre-
sented separately.
For each patient the number of unique somatic prescrip-
tions (issued by FP or specialist) was calculated in the year
prior to selection (thus repeats were excluded). This was
possible since both FPs and pharmacists use the same
computer system. We assumed this number to be a meas-
ure of actual treatment of somatic morbidity, increasing
the consultation rate generated by the CIRS. Moreover,
new prescriptions always generate FP-contact.
Analyses
Non-response analyses were conducted on gender, age,
consultation rate and prescriptions in the year preceding
baseline. Non-response on the screening questionnaire
was higher among younger male patients. The consulta-
tion rate among non-responders did not differ from
responders: 5.3 (se 0.2) versus 5.7 (se 0.2). Given the fact
that we included consulting patients the number that had
received one or more prescriptions of psycholeptics or
antidepressants in the preceding year was higher than one
would expect in a population sample, that is 26% and
15% respectively. Response was not affected by use of
medication. Among patients with or without prescrip-
tions of psycholeptics response rates were 61% and 58%
respectively (Chisquare value 1.742, p-value = 0.19).
Among patients with or without prescriptions of antide-
pressants response rates were 62% and 58% respectively
(Chisquare value 1.086, p-value = 0.30). Non-responders
to the interview scored on average 2 points higher on the
distress symptom score (HADS total) than responders on
the screening-questionnaire at baseline. Again, the con-
sultation rate and use of psycholeptics or antidepressants
among non-responders did not differ from responders.
Of the 473 interviewed patients 60 patients had an anxiety
and/or depressive disorder and 119 patients had a
somatoform disorder. The 119 patients with a somato-
form disorder had a total of 121 diagnoses: 93 undifferen-
tiated somatoform disorder, 13 chronic pain disorder, 9
hypochondriasis, 4 somatisation disorder and 2 conver-
sion disorder (body dysmorphic disorder was not diag-
nosed). A more detailed description of prevalence rates
and comorbidity can be found elsewhere [8]. Of the 400
interviewed patients with complete follow-up data on
health care use, 20 patients had only an anxiety/depres-
sive disorder, 94 patients had an undifferentiated somato-
form disorder or chronic pain disorder of whom 27 also
had an anxiety/depressive disorder, and 12 patients had
other somatoform disorder of whom 4 also had an anxi-
ety/depressive disorder. For the analyses patient numbers
were weighted by the inverse of their probability of selec-
tion to adjust for differential sampling. This made figures
representative for the original population.
FP-consultation rate was the main outcome measure.
Because of the skewed distribution both averages and
median were calculated. Incidence rate ratios (IRR) are
presented to quantify the influence of the presence of psy-
chiatric disorders on FP consultation rate. E.g., an IRR of
1.5 for disorder X is interpreted as an increase in consulta-
tion rate by 50% when disorder X is present [24]. IRRs
were obtained from negative binomial regression models.
Multivariate analyses were performed in STATA 9.1 by
negative binomial regression models that took into
account the sample scheme (survey statistics SVY: nbreg)
[25]. In the first step models were built including indica-
tor terms for the psychiatric disorders (not shown in
results section). In the second step the effect of potential
confounding variables was tested by including gender, age
and somatic morbidity ('CIRS somatic' and 'number of
unique somatic prescriptions') in the models (models 1
and 2 as reported in results section). We tested the effect
of excluding the confounding variable 'number of unique
somatic prescriptions', and it would only marginally
change the reported results since IRRs stayed within the
reported confidence intervals (not shown in results sec-
tion).
Results
Patients without psychiatric disorders had an average age
of 51 years, and 23% were over 65 (Table 1). Only a small
percentage of the patients with identified DSM-IV disor-
ders were over 65: 4% of patients with anxiety or depres-
sive disorders, 4% of patients with USD and 0% of
patients with other somatoform disorders. This is in line
with the low prevalence rates among the age group 65–79
years we reported earlier [8]. Somatic (co)morbidity was
equally distributed over all groups. Patients with DSM-IV-
defined disorders reported far more physical symptoms
on the PSC. Patients with no psychiatric disorders
reported an average of 4 physical symptoms, whereas
those with anxiety/depressive disorder, USD and other
somatoform disorders reported respectively 11, 10 and 15BMC Family Practice 2008, 9:5 http://www.biomedcentral.com/1471-2296/9/5
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physical symptoms. The latter also used more antidepres-
sants and anxiolytics.
Use of primary care during follow-up is summarized in
Table 2. Patients with none of the psychiatric disorders
had an average of 4.8 contacts with the FP during the fol-
low-up year. This is in accordance with figures reported by
the national statistics [26]. The patient groups with psy-
chiatric disorders had more FP-consultations than the
group without disorders. Despite the seemingly similar
somatic morbidity as measured by the CIRS (Table 1), the
number of non-psychiatric (somatic-related) prescrip-
tions tended to be higher in patients with psychiatric dis-
orders. E.g. patients with USD had an average of 12.4 (CI
95% 9.0–15.8) somatic prescriptions, while patients with-
out psychiatric disorders had 8.0 (95% CI 6.8–9.2). Data
from the follow-up questionnaire (follow-up at 6
months) showed that 39% of the patients with USD and
68% of patients with other somatoform disorders had had
contact with a psychiatrist, psychologist or social worker.
Of patients with anxiety or depressive disorder 59%
reported mental health treatment.
Table 3 shows the extent to which FP consultation was
predicted independently by psychiatric disorders and
CIRS somatic morbidity score. All models were addition-
ally corrected for patients' age and gender and the number
of unique somatic prescriptions in the year prior to fol-
low-up (IRRs not shown).
In the first model (model 1) undifferentiated somatoform
disorders contributed independently to the FP consulta-
tion rate: patients with an undifferentiated somatoform
disorders had a 1.3 times higher consultation rate than
patients without these disorders. Other somatoform dis-
orders and depressive disorders also showed this ten-
dency, though they were not significant. The presence of
an anxiety disorder did not contribute independently to
the consultation rate. Patients with a high level of somatic
morbidity had a 1.6 times higher consultation rate com-
pared to patients with a low level of somatic morbidity.
In model 2 the effect of having a single psychiatric disor-
der was compared to the effect of having two or more psy-
chiatric disorders. The FP consultation rate increased 1.4
times when a single disorder (somatoform or depressive
or anxiety) was diagnosed, and 1.8 times when two or
more of these disorders were present.
Discussion
Main findings
In our sample with 1046 primary care patients, those with
psychiatric disorders had more face-to-face contacts with
the FP in the follow-up year than patients without psychi-
atric disorders. In the FP's waiting room one out of six
patients will have a somatoform disorder and one out of
13 will have an anxiety or depressive disorder [8]. As we
found an average consultation rate of at least 7 within a
year, a FP in the Netherlands will see approximately 45
Table 1: Baseline measures. Data are weighted for the sampling scheme.
None of the 
psychiatric disorders
Anxiety or 
depressive disorder
Somatoform disorders, 
undifferentiated *
Somatoform 
disorder, others**
Total
Patient characteristics 
(questionnaire)
(n = 274) (n = 51) (n = 94) (n = 12) (n = 400)
Gender (men) 28% 28% 20% 17% 28%
Age:
- 65 and over 23% 4% 4% 0% 17%
- mean (se) 52 (0.8) 43 (1.3) 45 (1.0) 44 (2.8) 49 (0.6)
Physical symptoms (PSC total score) 4 (0.3) 11 (1.1) 10 (0.7) 15 (3.0) 6 (0.3)
Distress symptoms (HADS total score) 8 (0.3) 21 (1.1) 15 (0.8) 20 (2.3) 11 (0.4)
Health status
Somatic morbidity:
- CIRS somatic morbidity score 6.8 (0.2) 7.5 (0.5) 7.0 (0.4) 6.8 (0.9) 6.9 (0.2)
- Number of unique somatic prescriptions 
(FP or other)
5.0 (0.3) 6.3 (0.7) 6.3 (0.5) 5.7 (0.9) 5.4 (0.2)
Psychiatric morbidity:
- CIRS psychiatric severity score 0.4 (0.0) 1.5 (0.1) 1.0 (0.1) 1.7 (0.2) 0.6 (0.0)
Use of anxiolytics (self report at time of 
interview)
3% 14% 15% 8% 6%
Use of antidepressants (self report at time 
of interview)
5% 37% 25% 42% 12%
* Undifferentiated somatoform disorders included chronic pain disorders.
** Other somatoform disorders: hypochondriasis, somatization disorder and conversion disorder.BMC Family Practice 2008, 9:5 http://www.biomedcentral.com/1471-2296/9/5
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patients with these psychiatric disorders every week.
Undifferentiated somatoform disorders contributed inde-
pendently to a higher use of primary care after adjustment
for anxiety and depressive disorders: the FP consultation
rate increased by 30%.
Limitations of the study
Despite the scale of the SOUL study, a comprehensive
study including approximately 1000 consulting patients
with interviews and follow-up of 400 selected patients,
the power to estimate health care use for the more specific
somatoform disorders such as somatization disorder was
limited [8]. Disorders related to substance abuse, psy-
chotic disorders or personality disorders were not taken
into account.
For the main outcome measure, FP consultation rate, we
used the reliable electronic medical records of the FP. To
gather information on health care use by others than the
FP we relied on self-report data. Possibly, this might have
led to an over- or underestimation of this type of health
care use.
When comparing consultation rates of disorders one
should be aware of the effects of prescribing medication.
Particularly when dealing with anxiety and depressive dis-
orders a certain number of consultations will be initiated
by the FP to monitor the prescribed medication. On the
other hand, in the 'healthy group' there was a substantial
number of patients with current use of psycholeptics or
antidepressants, possibly disorders in remission.
Health care use and co-morbidity
An increased use of primary health care due to depressive
disorders has been reported repeatedly. In a general med-
ical setting in the USA Luber et al. found that patients
diagnosed as depressed had a significantly higher resource
utilization of all types; they had an average of 5.3 visits
compared to 2.9 visits for non-depressed patients [27].
Even symptoms of depression have been found to
increase consultation [28,29]. Considering the high rate
of co-morbidity, a substantial number of depressed
patients will have an additional somatoform disorder
[11,12,8].
This paper establishes that patients with undifferentiated
somatoform disorders more often visited the FP than
patients without psychiatric disorders, independent of the
presence of co-morbid anxiety or depressive disorders.
Other studies gave indications of an increased use of pri-
mary care in patients with undifferentiated somatoform
disorders [4,30,3,31], but they did not take into account
the considerable overlap between depressive and somato-
form disorders. Overlap was taken into account in two ret-
rospective studies. A general population study in
Germany confirmed that depression and somatization
both had an independent effect on health care use [32]. In
primary care practices in the USA, even after adjusting for
Table 2: Follow-up measures of medical consumption. Data are weighted for the sampling scheme.
None of the psychiatric 
disorder disorders
Anxiety or 
depressive disorder
Somatoform disorders, 
undifferentiated *
Somatoform 
disorder, others *
Total
Medical consumption (n = 274) (n = 51) (n = 94) (n = 12) (n = 400)
Data from patient records (1 yr):
Face-to-face contact with FP#:
mean (se) median 4.8 (0.2) 4 7.5 (0.9) 7 6.9 (0.6) 5 9.8 (3.5) 5.5 5.5 (0.3) 4
Somatic prescriptions by FP&:
mean (se) median 8.0 (0.6) 5 13.0 (3.6) 6 12.4 (1.7) 8 14.3 (4.2) 8.5 9.7 (0.7) 5
% use 86% 82% 95% 92% 87%
Antidepressants by FP&:
mean (se) median 0.4 (0.1) 0 3.5 (1.0) 0 2.1 (0.4) 0 4.7 (2.1) 1 1.0 (0.2) 0
% use 7% 40% 32% 58% 16%
Psycholeptics by FP&:
mean (se) median 0.6 (0.1) 0 4.2 (2.5) 0 2.3 (0.6) 0 4.9 (3.2) 0 1.5 (0.4) 0
% use 20% 37% 46% 25% 27%
Data from questionnaire (1/2 yr):
- contact with psychiatrist, 
psychologist or social worker
14% 59% 39% 68% 23%
- visit to hospital or specialist 48% 43% 48% 33% 48%
- admission to hospital 7% 14% 10% 0% 8%
* Undifferentiated somatoform disorders included chronic pain disorders. Other somatoform disorders: hypochondriasis, somatization disorder 
and conversion disorder. # Consultations and visits within office hours &FP prescriptions include repeats by FP of medication that was initiated by 
specialistsBMC Family Practice 2008, 9:5 http://www.biomedcentral.com/1471-2296/9/5
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the presence of psychiatric and medical comorbidity
somatizing patients had more outpatient and inpatient
medical care utilization than nonsomatizing patients
[33].
There are several aspects of the diagnosis 'undifferentiated
somatoform disorder' that may explain the patients' rea-
sons for consultation, such as diagnostic reassurance and
management of symptoms or limitations. Rief et al. stud-
ied different aspects of illness behaviour. For somatiza-
tion he found that behaviour focussed on body scanning
and medication/treatment. Depression was associated
with other aspects of illness behaviour that focussed on
expression of symptoms and illness consequences [32].
This is in accordance to findings that somatoform disor-
ders contribute independently to an increase in symptoms
and functional limitations, after adjustment for co-mor-
bid affective disorders [11,8].
Although mental disorders increase the utilization of gen-
eral medical health care, somatization does not necessar-
ily increase the utilization of mental health care [32,33].
In our study, 39% of patients with USD, 68% of patients
with other somatoform disorders and 59% of patients
with anxiety or depressive disorder received mental health
treatment in primary or secondary care. In a mental health
survey in the Dutch population (NEMESIS) it was found
that 34% of patients with mood disorders and 18% of
patients with anxiety disorders (DSM-III-R) had used
ambulatory mental health care in the past 12 months, not
including primary care psychologist or social worker (as
we did). Moreover, they found that people who had a life-
time history of psychiatric disorder but who had been dis-
order-free in the past 12 months still had a four times
higher use of mental health care compared to persons
with no lifetime disorder [1].
Conclusion
While we realize that the classification of somatoform dis-
orders has been debated [34,35] and in particular alterna-
tives of abridged forms of somatization disorder have
been studied in primary care, we judged it important to
diagnose somatoform disorders according to the prevail-
ing DSM-IV classification. It was found that the prevalent
entity "undifferentiated somatoform disorders" has a
prognostic value in terms of health care utilization. Since
both depressive and somatoform disorders contributed
independently to the use of primary care, we recommend
that health care planning should focus on recognition and
treatment of affective as well as somatoform disorders. An
integrative approach for both disorders could be advanta-
geous for patient and doctor.
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